Protein O-mannosylation is crucial for human mesencyhmal stem cells fate

Cellular and Molecular Life Sciences

Volumn 73, Issue 2, 2016, Pages 445-458

  Ragni, E ^a   Lommel, M ^b   Moro, M ^c   Crosti, M ^c   Lavazza, C ^a   Parazzi, V ^a   Saredi, S ^d   Strahl, S ^b   Lazzari, L ^a  

^a MAGGIORE HOSPITAL   (Italy)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Istituto Nazionale di Genetica Molecolare   (Italy)

^d DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Congenital muscular dystrophy; Differentiation; Extracellular vesicles; Mesenchymal stem cells; O Mannosylation; POMT1

Indexed keywords

MANNOSYLTRANSFERASE; MESSENGER RNA; PROTEIN O-MANNOSYLTRANSFERASE;

CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; GLYCOSYLATION; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; MUSCLE DEVELOPMENT; MUSCULAR DYSTROPHIES; MYOBLAST; PATHOLOGY;

CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION REGULATION; GLYCOSYLATION; HUMANS; MANNOSYLTRANSFERASES; MESENCHYMAL STROMAL CELLS; MUSCLE DEVELOPMENT; MUSCULAR DYSTROPHIES; MYOBLASTS; RNA, MESSENGER;

EID: 84954078670     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-015-2007-y     Document Type: Article

References (53)

1. Cook D, Genever P (2013) Regulation of mesenchymal stem cell differentiation. Adv Exp Med Biol 786:213-229. doi: 10.1007/978-94-007-6621-1-12
2. Bossolasco P, Corti S, Strazzer S, Borsotti C, Del Bo R, Fortunato F, Salani S, Quirici N, Bertolini F, Gobbi A et al (2004) Skeletal muscle differentiation potential of human adult bone marrow cells. Exp Cell Res 295(1):66-78
3. Montelatici E, Baluce B, Ragni E, Lavazza C, Parazzi V, Mazzola R, Cantarella G, Brambilla M, Giordano R, Lazzari L (2014) Defining the identity of human adipose-derived mesenchymal stem cells. Biochem Cell Biol 20:1-9
4. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147
5. Uezumi A, Ojima K, Fukada S, Ikemoto M, Masuda S, Miyagoe-Suzuki Y, Takeda S (2006) Functional heterogeneity of side population cells in skeletal muscle. Biochem Biophys Res Commun 341:864-873
6. Laino G, Graziano A, d'Aquino R, Pirozzi G, Lanza V, Valiante S, De Rosa A, Naro F, Vivarelli E, Papaccio G (2006) An approachable human adult stem cell source for hard-tissue engineering. J Cell Physiol 206:693-701
7. De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP (2001) Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 44:1928-1942
8. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, Fu YS, Lai MC, Chen CC (2004) Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 22:1330-1337
9. Romanov YA, Svintsitskaya VA, Smirnov VN (2003) Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 21:105-110
10. Barilani M, Lavazza C, Viganò M, Montemurro T, Boldrin V, Parazzi V, Montelatici E, Crosti M, Moro M, Giordano R et al (2015) Dissection of the cord blood stromal component reveals predictive parameters for culture outcome. Stem Cells Dev 24(1):104-114. doi: 10.1089/scd.2014.0160
11. Bernardo ME, Fibbe WE (2012) Safety and efficacy of mesenchymal stromal cell therapy in autoimmune disorders. Ann N Y Acad Sci 1266:107-117. doi: 10.1111/j.1749-6632.2012.06667.x.Review
12. Boregowda SV, Phinney DG (2012) Therapeutic applications of mesenchymal stem cells: current outlook. BioDrugs 26(4):201-208. doi: 10.2165/11632790-000000000-00000
13. György B, Hung ME, Breakefield XO, Leonard JN (2015) Therapeutic applications of extracellular vesicles: clinical promise and open questions. Annu Rev Pharmacol Toxicol 55:439-464. doi: 10.1146/annurevEVs-pharmtox-010814-124630
14. Roth Z, Yehezkel G, Khalaila I (2012) Identification and quantification of protein glycosylation. Int J Carbohydr Chem 2012. doi: 10.1155/2012/640923
15. Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME (eds) (2009) Essentials of glycobiology, Chapter 6, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor. ISBN-13: 9780879697709
16. Hamouda H, Ullah M, Berger M, Sittinger M, Tauber R, Ringe J, Blanchard V (2013) N-glycosylation profile of undifferentiated and adipogenically differentiated human bone marrow mesenchymal stem cells: towards a next generation of stem cell markers. Stem Cells Dev 22(23):3100-3113. doi: 10.1089/scd.2013.0108
17. Wells L (2013) The o-mannosylation pathway: glycosyltransferases and proteins implicated in congenital muscular dystrophy. J Biol Chem 288(10):6930-6935. doi: 10.1074/jbc.R112.438978
18. Manya H, Chiba A, Yoshida A, Wang X, Chiba Y, Jigami Y, Margolis RU, Endo T (2004) Demonstration of mammalian protein O-mannosyltransferase activity: coexpression of POMT1 and POMT2 required for enzymatic activity. Proc Natl Acad Sci USA 101(2):500-505
19. Willer T, Lee H, Lommel M, Yoshida-Moriguchi T, de Bernabe DB, Venzke D, Cirak S, Schachter H, Vajsar J, Voit T (2012) ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome. Nat Genet 44:575-580
20. Endo T (2015) Glycobiology of α-dystroglycan and muscular dystrophy. J Biochem 157(1):1-12. doi: 10.1093/jb/mvu066
21. Winder SJ (2001) The complexities of dystroglycan. Trends Biochem Sci 26:118-124
22. Goddeeris MM, Wu B, Venzke D, Yoshida-Moriguchi T, Saito F, Matsumura K, Moore SA, Campbell KP (2013) LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy. Nature 503(7474):136-140. doi: 10.1038/nature12605
23. Yoshida-Moriguchi T, Willer T, Anderson ME, Venzke D, Whyte T, Muntoni F, Lee H, Nelson SF, Yu L, Campbell KP (2013) SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function. Science 341(6148):896-899. doi: 10.1126/science.1239951
24. Inamori K, Yoshida-Moriguchi T, Hara Y, Anderson ME, Yu L, Campbell KP (2012) Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE. Science 335:93-96
25. Willer T, Inamori K, Venzke D, Harvey C, Morgensen G, Hara Y, Valero Beltrán, de Bernabé D, Yu L, Wright KM, Campbell KP (2014) The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated α-dystroglycan functional glycosylation. Elife 3. doi: 10.7554/eLife.03941
26. Yoshida-Moriguchi T, Willer T, Anderson ME, Venzke D, Whyte T, Muntoni F, Lee H, Nelson SF, Yu L, Campbell KP (2013) SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function. Science 341(6148):896-899. doi: 10.1126/science.1239951
27. Inamori K, Endo T, Gu J, Matsuo I, Ito Y, Fujii S, Iwasaki H, Narimatsu H, Miyoshi E, Honke K, Taniguchi N (2004) N-Acetylglucosaminyltransferase IX acts on the GlcNAc beta 1,2-Man alpha 1-Ser/Thr moiety, forming a 2,6-branched structure in brain O-mannosyl glycan. J Biol Chem 279(4):2337-2340
28. Ragni E, Montemurro T, Montelatici E, Lavazza C, Viganò M, Rebulla P, Giordano R, Lazzari L (2013) Differential microRNA signature of human mesenchymal stem cells from different sources reveals an "environmental-niche memory" for bone marrow stem cells. Exp Cell Res 319(10):1562-1574. doi: 10.1016/j.yexcr.2013.04.002
29. Ragni E, Viganò M, Rebulla P, Giordano R, Lazzari L (2013) What is beyond a qRT-PCR study on mesenchymal stem cell differentiation properties: how to choose the most reliable housekeeping genes. J Cell Mol Med 17(1):168-180. doi: 10.1111/j.1582-4934.2012.01660.x
30. Rojek JM, Campbell KP, Oldstone MB, Kunz S (2007) Old World arenavirus infection interferes with the expression of functional alpha-dystroglycan in the host cell. Mol Biol Cell 18(11):4493-4507
31. Orchard MG, Neuss JC, Galley CM, Carr A, Porter DW, Smith P, Scopes DI, Haydon D, Vousden K, Stubberfield CR et al (2004) Rhodanine-3-acetic acid derivatives as inhibitors of fungal protein mannosyl transferase 1 (PMT1). Bioorg Med Chem Lett 14(15):3975-3978
32. Arroyo J, Hutzler J, Bermejo C, Ragni E, García-Cantalejo J, Botías P, Piberger H, Schott A, Sanz AB, Strahl S (2011) Functional and genomic analyses of blocked protein O-mannosylation in baker's yeast. Mol Microbiol 79(6):1529-1546. doi: 10.1111/j.1365-2958.2011.07537.x
33. Lommel M, Winterhalter PR, Willer T, Dahlhoff M, Schneider MR, Bartels MF, Renner-Müller I, Ruppert T, Wolf E, Strahl S (2013) Protein O-mannosylation is crucial for E-cadherin-mediated cell adhesion. Proc Natl Acad Sci USA 110(52):21024-21029. doi: 10.1073/pnas.1316753110
34. Yoshida-Moriguchi T, Yu L, Stalnaker SH, Davis S, Kunz S, Madson M, Oldstone MB, Schachter H, Wells L, Campbell KP (2010) O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding. Science 327:88-92
35. Dobson CM, Hempel SJ, Stalnaker SH, Stuart R, Wells L (2013) OMannosylation and human disease. Cell Mol Life Sci 70(16):2849-2857. doi: 10.1007/s00018-012-1193-0
36. Yoshikawa HY, Kawano T, Matsuda T, Kidoaki S, Tanaka MJ (2013) Morphology and adhesion strength of myoblast cells on photocurable gelatin under native and non-native micromechanical environments. Phys Chem B 117(15):4081-4088. doi: 10.1021/jp4008224
37. Takeichi M (1995) Morphogenetic roles of classic cadherins. Curr Opin Cell Biol 7:619-627
38. Tepass U (1999) Genetic analysis of cadherin function in animal morphogenesis. Curr Opin Cell Biol 11:540-548
39. Gumbiner BM (2005) Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol 6:622-634
40. Gumbiner BM (1996) Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84:345-357
41. Erdmann B, Kirsch FP, Rathjen FG, Moré MI (2003) N-cadherin is essential for retinal lamination in the zebrafish. Dev Dyn 226(3):570-577
42. Kadowaki M, Nakamura S, Machon O, Krauss S, Radice GL, Takeichi M (2007) N-cadherin mediates cortical organization in the mouse brain. Dev Biol 304(1):22-33
43. Beltrán-Valero de Bernabé D, Currier S, Steinbrecher A, Celli J, van Beusekom E, van der Zwaag B, Kayserili H et al (2002) Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am J Hum Genet 71(5):1033-1043
44. Xu L, Meng F, Ni M, Lee Y, Li G (2013) N-cadherin regulates osteogenesis and migration of bone marrow-derived mesenchymal stem cells. Mol Biol Rep 40(3):2533-2539. doi: 10.1007/s11033-012-2334-0
45. Oberlender SA, Tuan RS (1994) Expression and functional involvement of N-cadherin in embryonic limb chondrogenesis. Development 120(1):177-187
46. Bian L, Guvendiren M, Mauck RL, Burdick JA (2013) Hydrogels that mimic developmentally relevant matrix and N-cadherin interactions enhance MSC chondrogenesis. Proc Natl Acad Sci USA 110(25):10117-10122. doi: 10.1073/pnas.1214100110
47. Haÿ E, Dieudonné FX, Saidak Z, Marty C, Brun J, Da Nascimento S, Sonnet P, Marie PJ (2014) N-cadherin/wnt interaction controls bone marrow mesenchymal cell fate and bone mass during aging. J Cell Physiol 229(11):1765-1775. doi: 10.1002/jcp.24629
48. Redfield A, Nieman MT, Knudsen KA (1997) Cadherins promote skeletal muscle differentiation in threedimensional cultures. J Cell Biol 138:1323-1331
49. Ladoux B, Anon E, Lambert M, Rabodzey A, Hersen P, Buguin A, Silberzan P, Mège RM (2010) Strength dependence of cadherin-mediated adhesions. Biophys J 98(4):534-542. doi: 10.1016/j.bpj.2009.10.044
50. Miyagoe-Suzuki Y, Masubuchi N, Miyamoto K, Wada MR, Yuasa S, Saito F, Matsumura K, Kanesaki H, Kudo A, Manya H, Endo T, Takeda S (2009) Reduced proliferative activity of primary POMGnT1-null myoblasts in vitro. Mech Dev 126(3-4):107-116. doi: 10.1016/j.mod.2008.12.001
51. Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, Collino F, Morando L, Busca A, Falda M, Bussolati B, Tetta C, Camussi G (2009) Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 20(5):1053-1067. doi: 10.1681/ASN.2008070798
52. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29(4):341-345. doi: 10.1038/nbt.1807
53. Zhuang X, Xiang X, Grizzle W, Sun D, Zhang S, Axtell RC, Ju S, Mu J, Zhang L, Steinman L et al (2011) Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther 19(10):1769-1779. doi: 10.1038/mt.2011.164